Vertec Scientific secures exclusive UK partnership with Seetreat Medical
Vertec Scientific has signed an exclusive agreement with Seetreat Medical to distribute the Art.1 radiotherapy workflow tool in the UK.
Art.1 is designed to support radiotherapy teams by simplifying and streamlining the treatment planning process. The system brings together key information in a clear and consistent way, helping departments improve efficiency, reduce the risk of error, and focus more closely on patient care.
As the sole distributor, Vertec Scientific will make Art.1 available to radiotherapy centres across the UK. With over 40 years of experience in providing advanced medical technology, the company will also deliver the training and ongoing support required for effective use of the system.
The partnership with Seetreat Medical reflects a shared commitment to improving cancer care through the adoption of innovative tools and technologies. By combining Seetreat’s expertise in workflow design with Vertec’s established presence in the UK healthcare sector, Art.1 will be well placed to make a positive impact on clinical practice.
